FR2258855A1 - - Google Patents

Info

Publication number
FR2258855A1
FR2258855A1 FR7502619A FR7502619A FR2258855A1 FR 2258855 A1 FR2258855 A1 FR 2258855A1 FR 7502619 A FR7502619 A FR 7502619A FR 7502619 A FR7502619 A FR 7502619A FR 2258855 A1 FR2258855 A1 FR 2258855A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7502619A
Other versions
FR2258855B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Publication of FR2258855A1 publication Critical patent/FR2258855A1/fr
Application granted granted Critical
Publication of FR2258855B1 publication Critical patent/FR2258855B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7502619A 1974-01-30 1975-01-28 Expired FR2258855B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB433974A GB1492029A (en) 1974-01-30 1974-01-30 4-oxo-1,4-dihydro-1,6-benzo-(h)-naphthyridine-3-carboxylic acid derivatives useful as anti-bacterial agents and their preparation

Publications (2)

Publication Number Publication Date
FR2258855A1 true FR2258855A1 (fr) 1975-08-22
FR2258855B1 FR2258855B1 (fr) 1978-07-21

Family

ID=9775330

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7502619A Expired FR2258855B1 (fr) 1974-01-30 1975-01-28

Country Status (3)

Country Link
JP (1) JPS50106999A (fr)
FR (1) FR2258855B1 (fr)
GB (1) GB1492029A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307078A1 (fr) * 1987-07-24 1989-03-15 Smithkline Beecham Intercredit B.V. Dérivés de la quinoléine, procédés pour leur préparation et compositions pharmaceutiques les contenant
FR2795729A1 (fr) * 1999-06-30 2001-01-05 Aventis Pharma Sa Nouveaux derives de la benzo[f]naphtyridine, leur preparation et les compositions les contenant
WO2001002396A1 (fr) * 1999-06-30 2001-01-11 Aventis Pharma S.A. NOUVEAUX DERIVES DE LA BENZO[f]NAPHTYRIDINE, LEUR PREPARATION ET LES COMPOSITIONS LES CONTENANT
WO2002020489A2 (fr) * 2000-09-06 2002-03-14 Bristol-Myers Squibb Company Inhibiteurs quinoline de la cgmp phosphodiesterase
WO2011031745A1 (fr) 2009-09-09 2011-03-17 Achaogen, Inc. Analogues de fluoroquinolone antibactériens

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2650279B1 (fr) * 1989-07-28 1991-10-18 Bellon Labor Sa Roger Nouveaux derives de benzonaphtyridine-1,8 leur preparation et les compositions qui les contiennent
NZ519380A (en) 1999-12-28 2004-10-29 Eisai Co Ltd Heterocyclic compounds having sulfonamide groups

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307078A1 (fr) * 1987-07-24 1989-03-15 Smithkline Beecham Intercredit B.V. Dérivés de la quinoléine, procédés pour leur préparation et compositions pharmaceutiques les contenant
US5051508A (en) * 1987-07-24 1991-09-24 Smithkline Beckman Intercredit B.V. Dihydropyrrolo quinoline derivatives
US6566362B2 (en) 1999-06-30 2003-05-20 Aventis Pharma S.A. Benzo[f]naphthyridine derivatives, their preparation and compositions containing them
WO2001002396A1 (fr) * 1999-06-30 2001-01-11 Aventis Pharma S.A. NOUVEAUX DERIVES DE LA BENZO[f]NAPHTYRIDINE, LEUR PREPARATION ET LES COMPOSITIONS LES CONTENANT
FR2795729A1 (fr) * 1999-06-30 2001-01-05 Aventis Pharma Sa Nouveaux derives de la benzo[f]naphtyridine, leur preparation et les compositions les contenant
WO2002020489A2 (fr) * 2000-09-06 2002-03-14 Bristol-Myers Squibb Company Inhibiteurs quinoline de la cgmp phosphodiesterase
WO2002020489A3 (fr) * 2000-09-06 2002-06-06 Bristol Myers Squibb Co Inhibiteurs quinoline de la cgmp phosphodiesterase
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
US6835737B2 (en) 2000-09-06 2004-12-28 Bristol-Myers Squibb Company Quinoline inhibitors of cGMP phosphodiesterase
US7173042B2 (en) 2000-09-06 2007-02-06 Bristol-Myers Squibb Company Quinoline inhibitors of cGMP phosphodiesterase
US7378430B2 (en) 2000-09-06 2008-05-27 Bristol-Myers Squibb Company Quinoline inhibitors of cGMP phosphodiesterase
US7384958B2 (en) 2000-09-06 2008-06-10 Bristol-Myers Squibb Company Quinoline inhibitors of cGMP phosphodiesterase
WO2011031745A1 (fr) 2009-09-09 2011-03-17 Achaogen, Inc. Analogues de fluoroquinolone antibactériens

Also Published As

Publication number Publication date
GB1492029A (en) 1977-11-16
FR2258855B1 (fr) 1978-07-21
JPS50106999A (fr) 1975-08-22

Similar Documents

Publication Publication Date Title
DK138254C (fr)
FR2275381B1 (fr)
FR2267836A1 (fr)
FR2258855B1 (fr)
FR2281964B1 (fr)
CS169245B1 (fr)
FR2275004B3 (fr)
JPS50126967A (fr)
JPS50104271A (fr)
FR2258174B1 (fr)
AU495028B2 (fr)
FR2280396B1 (fr)
JPS50111221U (fr)
JPS50119445A (fr)
AR198841Q (fr)
JPS50114241U (fr)
JPS50133296U (fr)
JPS50130900U (fr)
BE836964A (fr)
CH578234A5 (fr)
AU481639A (fr)
AU480977A (fr)
AU480540A (fr)
BG19639A1 (fr)
AU479634A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse